These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


243 related items for PubMed ID: 21832863

  • 1. A multicenter randomized double-blind 2-week comparison study of azelastine nasal spray 0.1% versus levocabastine nasal spray 0.05% in patients with moderate-to-severe allergic rhinitis.
    Han D, Chen L, Cheng L, Liu S, Fu Z, Zhang W, Wang C, Xi L, Zhang L, Chinese Allergic Rhinitis Collaborative Research Group (C2AR2G).
    ORL J Otorhinolaryngol Relat Spec; 2011; 73(5):260-5. PubMed ID: 21832863
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group.
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [Abstract] [Full Text] [Related]

  • 3. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
    Berger W, Hampel F, Bernstein J, Shah S, Sacks H, Meltzer EO.
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145
    [Abstract] [Full Text] [Related]

  • 4. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis.
    Falser N, Wober W, Rahlfs VW, Baehre M.
    Arzneimittelforschung; 2001 Sep; 51(5):387-93. PubMed ID: 11413739
    [Abstract] [Full Text] [Related]

  • 5. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH, Hampel F, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF, Corren J, Wheeler WJ, Berger WE, Rhinitis Study Group.
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial.
    LaForce C, Dockhorn RJ, Prenner BM, Chu TJ, Kraemer MJ, Widlitz MD, D'Eletto TA, Freitag JJ.
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):181-8. PubMed ID: 8595539
    [Abstract] [Full Text] [Related]

  • 8. Azelastine nasal spray as adjunctive therapy to azelastine tablets in the management of seasonal allergic rhinitis.
    Weiler JM, Meltzer EO.
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):327-32. PubMed ID: 9357378
    [Abstract] [Full Text] [Related]

  • 9. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
    Horak F, Zieglmayer UP, Zieglmayer R, Kavina A, Marschall K, Munzel U, Petzold U.
    Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
    Banov CH, Lieberman P, Vasomotor Rhinitis Study Groups.
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
    Berger WE, White MV, Rhinitis Study Group.
    Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis.
    van Bavel J, Howland WC, Amar NJ, Wheeler W, Sacks H.
    Allergy Asthma Proc; 2009 Aug; 30(5):512-8. PubMed ID: 19747429
    [Abstract] [Full Text] [Related]

  • 13. Azelastine nasal spray in the management of seasonal allergic rhinitis.
    Meltzer EO, Weiler JM, Dockhorn RJ, Widlitz MD, Freitag JJ.
    Ann Allergy; 1994 Apr; 72(4):354-9. PubMed ID: 7908778
    [Abstract] [Full Text] [Related]

  • 14. [Investigation of the efficacy and tolerability of azelastine nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis].
    Antépara I, Jaúregui I, Basomba A, Cadahia A, Feo F, García JJ, Gonzalo MA, Luna I, Rubio M, Vázquez M.
    Allergol Immunopathol (Madr); 1998 Apr; 26(1):9-16. PubMed ID: 9585822
    [Abstract] [Full Text] [Related]

  • 15. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
    Hampel FC, Ratner PH, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
    [Abstract] [Full Text] [Related]

  • 16. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
    Shah SR, Nayak A, Ratner P, Roland P, Michael Wall G.
    Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily.
    Lumry W, Prenner B, Corren J, Wheeler W.
    Ann Allergy Asthma Immunol; 2007 Sep; 99(3):267-72. PubMed ID: 17910331
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis.
    Shah S, Berger W, Lumry W, La Force C, Wheeler W, Sacks H.
    Allergy Asthma Proc; 2009 Sep; 30(6):628-33. PubMed ID: 19930788
    [Abstract] [Full Text] [Related]

  • 19. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
    Lieberman P, Kaliner MA, Wheeler WJ.
    Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W, Diez Crespo CD, Bähre M.
    Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.